Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor.

The Journal of Biological Chemistry
D K MoscatelloA J Wong

Abstract

The most frequently found alteration of the epidermal growth factor receptor (EGFR) in human tumors is a deletion of exons 2-7. This receptor, termed EGFRvIII, can transform NIH 3T3 cells, and the frequent expression of this variant implies that it confers a selective advantage upon tumor cells in vivo. Although EGFRvIII is a constitutively activated tyrosine kinase, there is no increase in Ras.GTP levels and low levels of mitogen-activated protein kinase activity in NIH 3T3 cells expressing this variant. We investigated whether phosphatidylinositol (PI) 3-kinase was an effector in transformation by the EGFRvIII. High levels of PI 3-kinase activity were constitutively present in EGFRvIII-transformed cells and were dependent upon the kinase activity of the receptor. While mitogen-activated protein kinase activity was quickly down-regulated to basal levels after 12 h of continuous EGFR activation, there was a 3-fold increase in PI 3-kinase activity in cells expressing normal EGFR and an 8-fold increase in cells expressing EGFRvIII after 48 h. This increased activity may reflect enhanced binding to EGFRvIII and the presence of novel PI 3-kinase isoforms. Treatment with the PI 3-kinase inhibitors wortmannin and LY294002 blocked bot...Continue Reading

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P A HumphreyD D Bigner
Jul 17, 1995·International Journal of Cancer. Journal International Du Cancer·K SchwechheimerW K Cavenee
Jul 28, 1995·The Journal of Biological Chemistry·K F ToliasC L Carpenter
Mar 24, 1995·Science·A Levitzki, A Gazit
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·R NishikawaH J Huang
Aug 1, 1994·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R Kapeller, L C Cantley
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·S RocheS A Courtneidge
Jan 2, 1994·International Journal of Cancer. Journal International Du Cancer·J SchlegelM Kiessling
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·K M Pumiglia, S J Decker
Feb 7, 1997·Cell·T Hunter

❮ Previous
Next ❯

Citations

Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·R Bruce Montgomery
Feb 24, 2001·Brain Tumor Pathology·C T KuanD D Bigner
Aug 11, 2007·World Journal of Urology·G J VillaresMenashe Bar-Eli
Feb 22, 2008·Histochemistry and Cell Biology·Kirstine RoepstorffBo van Deurs
Feb 9, 2006·Current Oncology Reports·Monika E Hegi, Roger Stupp
Oct 23, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Oliver RennerAmancio Carnero
Mar 12, 2004·Cancer Letters·Ana Ramírez de MolinaJuan Carlos Lacal
Feb 10, 2004·Cancer Treatment Reviews·Janessa J Laskin, Alan B Sandler
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Robert D Mass
Dec 31, 2003·Molecular and Cellular Neurosciences·John A BoockvarDonald M O'Rourke
Mar 21, 2003·Biochemical and Biophysical Research Communications·Yasuyoshi MiyataShigeru Kanda
Mar 22, 2003·Experimental Cell Research·Julie L BoernerNita J Maihle
Jul 18, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Fred R HirschWilbur A Franklin
Jul 20, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Mathias Schmidt, Rosemarie B Lichtner
Jan 11, 2011·Journal of Proteome Research·Vaibhav ChumbalkarOliver Bogler
Nov 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Daxing XieJer-Tsong Hsieh
Jun 19, 2003·Journal of the National Cancer Institute·Viktor Grünwald, Manuel Hidalgo
Jun 16, 2005·Journal of the National Cancer Institute·Daphne A Haas-KoganDavid Stokoe
Nov 1, 2001·Annual Review of Cell and Developmental Biology·R KatsoM D Waterfield
Jul 22, 2011·Journal of Signal Transduction·Lisa A Elferink, Vicente A Resto
Apr 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah E WheelerJennifer R Grandis
Jul 22, 2011·Molecular Cancer Research : MCR·Yeohyeon HwangOliver Bogler
Oct 6, 2005·Onkologie·Yosef Yarden
Oct 1, 2009·Journal of Experimental & Clinical Cancer Research : CR·Xiao-yi DuanJian-sheng Wang
Apr 4, 2002·Drugs & Aging·Carol J Fabian, Bruce F Kimler
Nov 18, 2011·ISRN Oncology·Annamaria Cimini, Rodolfo Ippoliti
Jan 5, 2011·Chinese Journal of Cancer·Jill WykoskyWebster K Cavenee

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.